Abstract
Mitral regurgitation (MR) is a common complication in heart failure patients, severely worsening their outcome. Because of the high perioperative risk, mitral valve surgery, which is the standard therapy for MR, is often not offered to these patients. Interventional therapies for mitral valve therapy might therefore constitute a novel therapeutic option particularly in this group. This article gives an overview of the available and evolving interventional strategies for mitral valve repair with a special emphasis on heart failure patients.
Zusammenfassung
Die funktionelle Mitralklappeninsuffizienz ist eine häufige, sich prognostisch ungünstig auswirkende Komplikation bei schwerer Herzinsuffizienz. Gerade bei Patienten mit hochgradig eingeschränkter linksventrikulärer Funktion wird eine operative Versorgung der Mitralklappe aufgrund des deutlich erhöhten perioperativen Risikos häufig abgelehnt. Kathetergestützte, interventionelle Verfahren zur Therapie der Mitralklappeninsuffizienz könnten hier eine potenzielle Alternative darstellen. Der vorliegende Artikel gibt einen Überblick über vorhandene und sich in Entwicklung befindliche interventionelle Verfahren bei Mitralklappeninsuffizienz, wobei die Versorgung von Patienten mit Herzinsuffizienz im Fokus steht.
Similar content being viewed by others
References
Acker MA, Jessup M, Bolling SF, Oh J et al (2011) Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial. J Thorac Cardiovasc Surg 142:569–574, 574.e1
Agricola E, Oppizzi M, Maisano F, De Bonis M et al (2004) Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern. Eur J Echocardiogr 5:326–334
Alfieri O, Maisano F, De Bonis M, Stefano PL et al (2001) The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 122:674–681
Auricchio A, Schillinger W, Meyer S, Maisano F et al (2011) Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodeling. J Am Coll Cardiol 58:2183–2189
Baldus S, Schillinger W, Franzen O, Bekeredjian R et al (2012) MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail
Bouma W, Horst IC van der, Wijdh-den Hamer IJ, Erasmus ME et al (2010) Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches. Eur J Cardiothorac Surg 37:170–185
Burch GE, De Pasquale NP, Phillips JH (1963) Clinical manifestations of papillary muscle dysfunction. Arch Intern Med 112:112–117
Conti JB, Mills RM (1993) Mitral regurgitation and death while awaiting cardiac transplantation. Am J Cardiol 71:617–618
Dent JM, Spotnitz WD, Nolan SP, Jayaweera AR et al (1995) Mechanism of mitral leaflet excursion. Am J Physiol 269:H2100–H2108
Fedak PW, McCarthy PM, Bonow RO (2008) Evolving concepts and technologies in mitral valve repair. Circulation 117:963–974
Feldman T, Foster E, Glower DG, Kar S et al (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406
Feldman T, Cilingiroglu M (2011) Percutaneous leaflet repair and annuloplasty for mitral regurgitation. J Am Coll Cardiol 57:529–537
Franzen O, Baldus S, Rudolph V, Meyer S et al (2010) Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J 31:1373–1381
Franzen O, Heyden J van der, Baldus S, Schlüter M et al (2011) MitraClip(R) therapy in patients with end-stage systolic heart failure. Eur J Heart Fail 13:569–576
Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR et al (2001) Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103:1759–1764
Harnek J, Webb JG, Kuck KH, Tschope C et al (2011) Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). JACC Cardiovasc Interv 4:115–122
Head SJ, Kaul S, Bogers AJ, Kappetein AP (2012) Non-inferiority study design: lessons to be learned from cardiovascular trials. Eur Heart J. 33:1318–1324
Kanzaki H, Bazaz R, Schwartzman D, Dohi K et al (2004) A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol 44:1619–1625
Koelling TM, Aaronson KD, Cody RJ, Bach DS et al (2002) Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144:524–529
Lancellotti P, Lebrun F, Piérard LA (2003) Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 42:1921–1928
Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ et al (1996) Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335:1417–1423
Maisano F, Vanermen H, Seeburger J et al (2012) Direct access transcatheter mitral annuloplasty with a sutureless and adjustable device: preclinical experience. Eur J Cardiothorac Surg 42:524–529
Mauri L, Garg P, Massaro JM, Foster E et al (2010) The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. Am Heart J 160:23–29
McCullough PA, Philbin EF, Spertus JA, Kaatz S et al (2002) Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39:60–69
Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M et al (2007) Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol 49:2191–2201
Mirabel M, Iung B, Baron G, Messika-Zeitoun D et al (2007) What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 28:1358–1365
Nagasaki M, Nishimura S, Ohtaki E, Kasegawa H et al (2006) The echocardiographic determinants of functional mitral regurgitation differ in ischemic and non-ischemic cardiomyopathy. Int J Cardiol 108:171–176
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005–1011
Pecini R, Thune JJ, Torp-Pedersen C, Hassager C et al (2011) The relationship between mitral regurgitation and ejection fraction as predictors for the prognosis of patients with heart failure. Eur J Heart Fail 13:1121–1125
Pleger ST, Mereles D, Schulz-Schönhagen M, Krumsdorf U et al (2011) Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Am J Cardiol 108:1478–1482
Rudolph V, Knap M, Franzen O, Schlüter M et al (2011) Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. J Am Coll Cardiol 58:2190–2195
Schillinger W, Athanasiou T, Weicken N, Berg L et al (2011) Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. Eur J Heart Fail 13:1331–1339
Schofer J, Siminiak T, Haude M, Herrman JP et al (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120:326–333
Siminiak T, Wu JC, Haude M, Hoppe UC et al (2012) Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 14:931–938
Tamburino C, Ussia GP, Maisano F, Capodanno D et al (2010) Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 31:1382–1389
Vahanian A, Alfieri O, Andreotti F, Antunes MJ et al (2012) Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J
Van den Branden BJ, Swaans MJ, Post MC, Rensing BJ et al (2012) Percutaneous edge-to-edge mitral valve repair in high-surgical-risk patients: do we hit the target? JACC Cardiovasc Interv 5:105–111
Watanabe N, Ogasawara Y, Yamaura Y, Wada N et al (2005) Mitral annulus flattens in ischemic mitral regurgitation: geometric differences between inferior and anterior myocardial infarction: a real-time 3-dimensional echocardiographic study. Circulation 112:I458–I462
Whitlow PL, Feldman T, Pedersen WR, Lim DS et al (2012) Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study. J Am Coll Cardiol 59:130–139
Wu AH, Aaronson KD, Bolling SF, Pagani FD et al (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45:381–387
Yu HY, Su MY, Liao TY, Peng HH et al (2004) Functional mitral regurgitation in chronic ischemic coronary artery disease: analysis of geometric alterations of mitral apparatus with magnetic resonance imaging. J Thorac Cardiovasc Surg 128:543–551
Conflict of interest
On behalf of all authors, the corresponding author states the following: S.B. has received an unrestricted research grant from Abbott Vascular.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rudolph, V., Baldus, S. Mitral regurgitation in patients with heart failure. Herz 38, 136–142 (2013). https://doi.org/10.1007/s00059-012-3748-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-012-3748-0